Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History INZY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics INZY

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Inozyme Pharma Inc

INZY
Current price
4.00 USD 0 USD (0.00%)
Last closed 4.00 USD
ISIN US45790W1080
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 258 247 200 USD
Yield for 12 month -13.04 %
1Y
3Y
5Y
10Y
15Y
INZY
21.11.2021 - 28.11.2021

Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function. The company's lead product candidate consists of INZ-701, a soluble, recombinant, genetically engineered, and ENPP1 fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, and calciphylaxis, as well as patients with end-stage kidney disease receiving hemodialysis. It also develops Next Gen ERT for the treatment of ossification of the posterior longitudinal ligament (OPLL); and Gene therapy, a disease of the PPi-Adenosine Pathway. The company has license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts. Address: 321 Summer Street, Boston, MA, United States, 02210

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.00 USD

P/E Ratio

Dividend Yield

Financials INZY

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures INZY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-1 294 000 USD

Current Quarter

Last Quarter

EBITDA -104 737 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -48.45 %
PEG Ratio
Return On Equity TTM -141.69 %
Wall Street Target Price 4.00 USD
Revenue TTM
Book Value 0.49 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.68 USD
Diluted Eps TTM -1.68 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation INZY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -4.25
Price Book MRQ 8.12

Technical Indicators INZY

For 52 Weeks

0.72 USD 6.24 USD
50 Day MA 2.91 USD
Shares Short Prior Month 3 680 379
200 Day MA 2.78 USD
Short Ratio 0.78
Shares Short 3 384 905
Short Percent 5.67 %